Blockade of a clotting protein during stroke process reduces brain damage in experimental models

by CIMA - Centro de Investigación Médica Aplicada

Researchers at the Cima University of Navarra confirm for the first time that FXIII increases clot density and resistance to current treatments in thrombi of stroke patients

Read more

Anaconda announces first-in-human study of next-generation thrombectomy system

by CataloniaBio

Anacon​da Biomed, a medical technology company developing a next-generation​ thrombectomy system for the treatment of ischemic stroke, has announced the completion of initial patient cases in a fi...

Read more

Gene vital for post-stroke recovery identified for the first time

by Vall d’Hebron

Having certain specific variants of the PATJ gene predisposes to worse recovery from ischemic stroke. 7 out of 10 patients with these variants suffer severe sequelae three months after having a stroke...

Read more

New animal model for studying ischemic stroke

by Vall d’Hebron

The use of pigs has allowed also to deepen the operation of certain cell receptors involved in the disease. In particular, SUR1 and TRMP4 receptors are investigated, which are not found in nerve cells...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream